Here are relevant reports on : diabetes-care-devices-market
-
Autoinjectors Market by Type (Devices, Finished Formulation), Usage (Disposable, Reusable), Actuation Mechanism (Mechanical, Electronic), Therapy (Rheumatoid Arthritis, Obesity, Diabetes), ROA (SC, IM), Volume (< 3ml, > 3ml) - Global Forecast to 2031
The global autoinjectors market is projected to reach USD 300.46 billion by 2031, growing at a CAGR of 18.7% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Infusion Pump Market by Product (Accessories (Dedicated, Non-dedicated), Devices (Insulin, Syringe, Volumetric, Enteral, PCA Pump)), Technology (Traditional, Specialty), Mode (Stationary, Portable), Application (Cancer, Diabetes) - Global Forecast to 2030
The global infusion pump market, valued at US$18.5 billion in 2024, stood at US$19.9 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2030, culminating in a forecasted valuation of US$ 28.3 billion by the end of the period. The infusion pump market is expanding rapidly, driven by significant technological advancements in smart, interconnected, and automated systems that optimize the precision and safety of infusion therapy.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
ASEAN Infusion Pump Market by Product (Accessories (Dedicated (Volumetric Pumps, Insulin Pumps, Enteral Pumps) & Non-dedicated), Devices (Traditional, Specialty)), Application (Oncology, Diabetes, Pain Management), End User - Global Forecast to 2030
The global ASEAN infusion pump market, valued at US$1.18 billion in 2024, stood at US$1.26 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2025 to 2030, culminating in a forecasted valuation of US$1.78 billion by the end of the period. The ASEAN infusion pump market is experiencing significant growth, driven by heightened healthcare awareness and enhanced access to sophisticated medical technologies throughout the region.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
North America Injectable Drug Delivery Market – by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Forecasts to 2017
The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it is expected to reach $16.6 billion by 2017 at a CAGR of 12.3% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The North American injectable drug delivery formulations technologies market was the largest segment in this market. In addition, the market is segmented on the basis of its therapeutic applications. In therapeutic area, hormonal disorders command the major segment of injectable drug delivery technologies market due to high demand of injectable in treatment of diabetes. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self injection devices.
- Published: April 2013
- Price: $ 4950
- TOC Available:
-
Respiratory Care Devices Market by Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), Disease Indication (Asthma, Infectious Disease), End User (Hospitals, Homecare Settings) - Global Forecast to 2030
The global respiratory care devices market, valued at US$22.2 billion in 2024, stood at US$23.6 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2030, culminating in a forecasted valuation of US$33.6 billion by the end of the period. Various demographic, medical, and environmental factors propel market growth in respiratory care equipment. Among these is the increase in the global prevalence of respiratory conditions.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Sinus Dilation Devices Market by Product (Balloon Dilation Devices, Endoscope (Rhinoscope, Sinoscope), Handheld), Procedure (Standalone, Hybrid), Patient Type (Adult, Pediatric) & Patient Care Setting (Hospitals & ASC, ENT Office) - Global Forecast to 2027
The global sinus dilation devices market growth is primed to transition from USD 2.8 billion in 2022 to USD 3.8 billion by 2027, showcasing a strong CAGR of 6.6%. The expansion of this market is due in large part to the upsurge in cases of chronic sinusitis as well as growing healthcare spending. However, a lack of skilled ENT professionals is one of the challenges that may inhibit the growth of this market.
- Published: August 2022
- Price: $ 4950
- TOC Available:
-
US Respiratory Care Device Market by Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), Disease Indication (Asthma, Infectious Disease), End User (Hospitals, Home Care Settings) - Forecast to 2031
The US Respiratory Care Devices market, valued at US$9.40 billion in 2025, stood at US$10.02 billion in 2026 and is projected to advance at a resilient CAGR of 7.8% from 2026 to 2031, culminating in a forecasted valuation of US$14.56 billion by the end of the period. This growth is primarily driven by an increasing prevalence of chronic respiratory diseases such as COPD, asthma, and sleep apnea, along with an aging population that is more susceptible to breathing disorders.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
US Wound Care Market by Product [Dressings (Foam, Hydrocolloid, Collagen), Devices (NPWT, Debridement), Biological Skin Substitutes, Sutures, Staplers], Wound [Chronic, Acute], End User [Hospitals, Clinics, Home Care]-Forecast to 2031
The US wound care market, valued at USD 6.63 billion in 2025, stood at USD 7.01 billion in 2026 and is projected to advance at a resilient CAGR of 6.1% from 2026 to 2031, culminating in a forecasted valuation of USD 9.44 billion by the end of the period. The growth of US wound care products is primarily driven by trauma and burn injuries, the rising prevalence of chronic diseases, and the growing geriatric population.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Europe Wound Care Market by Product [Dressings (Foam, Hydrocolloid, Collagen), Devices (NPWT, Debridement), Biological Skin Substitutes, Sutures, Staplers], Wound [Chronic, Acute], End User [Hospitals, Clinics, Home Care] -Forecast to 2031
The Europe Wound Care Market, valued at USD 6.62 billion in 2025, stood at USD 6.98 billion in 2026 and is projected to advance at a resilient CAGR of 6.0% from 2026 to 2031, culminating in a forecasted valuation of USD 9.33 billion by the end of the period. Growth momentum across Europe is fueled by the integration of advanced wound care technologies into European healthcare infrastructure, an emphasis on early diagnosis, and the development of wound care products for chronic and acute wounds.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Europe Digital Diabetes Management Market by Product (Device (CGM, Smart Glucometer, Insulin Patch Pump), Diabetes Apps, Service, Software & Platforms), Device Type (Handheld & Wearables), End User (Self/Home Healthcare) - Forecast to 2031
The Europe digital diabetes management market, valued at USD 6.89 billion in 2025, stood at USD 7.78 billion in 2026 and is projected to advance at a resilient CAGR of 10.0% from 2026 to 2031, culminating in a forecasted valuation of USD12.53 billion by the end of the period. Europe is a significant enabler of digital diabetes management. These devices generate continuous, real-time data that can be integrated into digital platforms for monitoring, alerts, and personalized insights.
- Published: September 2026
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
